Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause.
Polyneuropathy, Amyloidosis
About this trial
This is an interventional screening trial for Polyneuropathy
Eligibility Criteria
Inclusion Criteria: Patients with chronic axonal length-dependent polyneuropathy (CAP) and/or small-fiber neuropathy (SFN) without well-defined etiology. Age: >= 60 years Male and female gender Written informed consent Exclusion Criteria: Known cause of polyneuropathy Other types of peripheral neuropathy than chronic axonal length-dependent polyneuropathy (CAP) and/or small-fiber neuropathy (SFN). Patients younger than 60 years
Sites / Locations
- UZ BrusselRecruiting
Arms of the Study
Arm 1
Other
1 arm including patients with CAP and/or SFN
1 arm including patients with chronic axonal length-dependent polyneuropathy and/or small-fiber neuropathy. All participants will be screened with ECG and echocardiography. All participants will be asked to complete questionnaires about there polyneuropathy and cardiological symptoms.